CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

i3solutions

i3solutions is a Sterling, VA-based company in the Business Services sector.

Corridor

Award-winning enterprise Contract Management Solutions from Contracts 365 provides Legal complete visibility and control of their contract process.

Down Payment Resource

Down Payment Resource creates opportunity for homebuyers, Realtors and lenders by uncovering programs that get people into homes. The tool is licensed to Multiple Listing Services, Realtor Associations, lenders and housing counselors across the country.

Belcan Corporation

Belcan Corporation is a Chattanooga, TN-based company in the Business Services sector.

Pacific Party Canopies

Pacific Party Canopies is a Burlington, WA-based company in the Business Services sector.